AstraZeneca (AZN)
AstraZeneca Free Cash Flow (Quarterly):
-474.00M for March 31, 2018AstraZeneca Free Cash Flow (Quarterly) Chart
AstraZeneca Historical Free Cash Flow (Quarterly) Data
| Data for this Date Range | |
|---|---|
| March 31, 2018 | -474.00M |
| Dec. 31, 2017 | 446.00M |
| Sept. 30, 2017 | 1.89B |
| June 30, 2017 | -81.00M |
| March 31, 2017 | -297.00M |
| Dec. 31, 2016 | 1.319B |
| Sept. 30, 2016 | 445.00M |
| June 30, 2016 | -820.00M |
| March 31, 2016 | 887.00M |
| Dec. 31, 2015 | 36.00M |
| Sept. 30, 2015 | 1.211B |
| June 30, 2015 | 436.00M |
| March 31, 2015 | -1.147B |
| Dec. 31, 2014 | 1.373B |
| Sept. 30, 2014 | 1.535B |
| June 30, 2014 | 939.00M |
| March 31, 2014 | 459.00M |
| Dec. 31, 2013 | 1.692B |
| Sept. 30, 2013 | 644.00M |
| June 30, 2013 | 1.222B |
| March 31, 2013 | 1.784B |
| Dec. 31, 2012 | 2.284B |
| Sept. 30, 2012 | -2.263B |
| June 30, 2012 | 970.00M |
| March 31, 2012 | 1.338B |
| Dec. 31, 2011 | 2.691B |
| Sept. 30, 2011 | 1.679B |
| June 30, 2011 | 535.00M |
| March 31, 2011 | 1.619B |
| Dec. 31, 2010 | 3.093B |
| Sept. 30, 2010 | 2.124B |
| June 30, 2010 | 2.546B |
| March 31, 2010 | 736.00M |
| Dec. 31, 2009 | 3.496B |
| Sept. 30, 2009 | 1.867B |
| June 30, 2009 | 2.847B |
| March 31, 2009 | 1.943B |
| Dec. 31, 2008 | 2.298B |
| Sept. 30, 2008 | 1.358B |
| June 30, 2008 | 1.594B |
| March 31, 2008 | -547.00M |
| Dec. 31, 2007 | 2.527B |
| Sept. 30, 2007 | 875.00M |
| June 30, 2007 | 647.00M |
| March 31, 2007 | 1.782B |
| Dec. 31, 2006 | 1.875B |
| Sept. 30, 2006 | 1.762B |
| June 30, 2006 | 1.386B |
| March 31, 2006 | 1.331B |
| Dec. 31, 2005 | 1.842B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
AZN Free Cash Flow (Quarterly) Benchmarks
| Benchmarks | |
|---|---|
| GlaxoSmithKline | 706.38M |
| Sanofi | -- |
| Bristol-Myers Squibb | 936.00M |
AZN Free Cash Flow (Quarterly) Range, Past 5 Years
| Minimum | -1.147B | Mar 2015 |
| Maximum | 1.89B | Sep 2017 |
| Average | 585.75M |
AZN Free Cash Flow (Quarterly) Excel Add-In Codes
- Metric Code: free_cash_flow
- Latest data point: =YCP("AZN", "free_cash_flow")
- Last 5 data points: =YCS("AZN", "free_cash_flow", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
AZN News
MT Newswires 05/25 05:42 ET
Business Wire 05/24 08:00 ET
